[1]
Ayesha Erum Hadi et al. 2024. EXAMINING CD133, C-MYC, AND AXL EXPRESSION IN COLON ADENOCARCINOMAS: PROGNOSTIC VALUE AND CLINICAL ASSOCIATIONS. Journal of Population Therapeutics and Clinical Pharmacology. 31, 5 (May 2024), 273–283. DOI:https://doi.org/10.53555/jptcp.v31i5.6138.